Exploring Infortumab's Role in Breast Cancer Treatment

This chapter explores the application of infortumab for breast cancer, referencing its prior effectiveness in metastatic bladder cancer alongside pembrolizumab. It outlines the patient cohorts examined, the challenges with meeting primary endpoints, and the management of toxicity, particularly skin reactions.